Expression and prognostic impact of CD73 in classical Hodgkin lymphoma

Abstract Relapsed or refractory classical Hodgkin lymphoma (cHL) remains a clinical challenge, underscoring the need for early identification of high-risk patients to guide treatment stratification. CD73, an ectoenzyme involved in adenosine production, plays a key role in immunosuppression and tumor...

詳細記述

書誌詳細

主要な著者:	Beichen Liu, Cuiying He, Haisheng Liu, Guangyu Ma, Shuo Zhang, Yan Liu, Caili Liu, Kexin Li, Yunzhe Wang, Yueping Liu, Meng Yue, Chang Liu, Xiaoxiao Wang, Shaoning Yin, Zheng Li
フォーマット:	Artigo
言語:	Inglês
出版事項:	Springer 2026-04-01
シリーズ:	Annals of Hematology
主題:	CD73 Classical Hodgkin lymphoma Immune checkpoint inhibitor Prognostic factor Relapsed/refractory lymphoma
オンライン･アクセス:	https://doi.org/10.1007/s00277-026-06987-1
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!